ARRJF
Price
$3.50
Change
+$0.43 (+14.01%)
Updated
Sep 25 closing price
Capitalization
927.23M
PDRX
Price
$2.85
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
Capitalization
N/A
Interact to see
Advertisement

ARRJF vs PDRX

Header iconARRJF vs PDRX Comparison
Open Charts ARRJF vs PDRXBanner chart's image
Arjo AB
Price$3.50
Change+$0.43 (+14.01%)
Volume$100
Capitalization927.23M
PD-RX Pharmaceuticals
Price$2.85
Change-$0.00 (-0.00%)
Volume$480
CapitalizationN/A
ARRJF vs PDRX Comparison Chart in %
Loading...
ARRJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRJF vs. PDRX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRJF is a Buy and PDRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (ARRJF: $3.50 vs. PDRX: $2.85)
Brand notoriety: ARRJF and PDRX are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: ARRJF: 2% vs. PDRX: 20%
Market capitalization -- ARRJF: $927.23M vs. PDRX: $0
ARRJF [@Medical Distributors] is valued at $927.23M. PDRX’s [@Medical Distributors] market capitalization is $0. The market cap for tickers in the [@Medical Distributors] industry ranges from $94.6B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARRJF’s FA Score shows that 1 FA rating(s) are green whilePDRX’s FA Score has 0 green FA rating(s).

  • ARRJF’s FA Score: 1 green, 4 red.
  • PDRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ARRJF is a better buy in the long-term than PDRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRJF’s TA Score shows that 0 TA indicator(s) are bullish while PDRX’s TA Score has 1 bullish TA indicator(s).

  • ARRJF’s TA Score: 0 bullish, 1 bearish.
  • PDRX’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, ARRJF is a better buy in the short-term than PDRX.

Price Growth

ARRJF (@Medical Distributors) experienced а +14.01% price change this week, while PDRX (@Medical Distributors) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +1.13%. For the same industry, the average monthly price growth was +3.16%, and the average quarterly price growth was +3.38%.

Industries' Descriptions

@Medical Distributors (+1.13% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRJF YTD gains are higher at: 14.007 vs. PDRX (-6.557).
ARRJFPDRXARRJF / PDRX
Capitalization927MN/A-
EBITDA1.97BN/A-
Gain YTD14.007-6.557-214%
P/E Ratio20.84N/A-
Revenue11.3BN/A-
Total Cash766MN/A-
Total Debt1.19BN/A-
FUNDAMENTALS RATINGS
ARRJF vs PDRX: Fundamental Ratings
ARRJF
PDRX
OUTLOOK RATING
1..100
4646
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
44
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
84100
PRICE GROWTH RATING
1..100
4752
P/E GROWTH RATING
1..100
52100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARRJF's Valuation (17) in the null industry is in the same range as PDRX (44). This means that ARRJF’s stock grew similarly to PDRX’s over the last 12 months.

ARRJF's Profit vs Risk Rating (100) in the null industry is in the same range as PDRX (100). This means that ARRJF’s stock grew similarly to PDRX’s over the last 12 months.

ARRJF's SMR Rating (84) in the null industry is in the same range as PDRX (100). This means that ARRJF’s stock grew similarly to PDRX’s over the last 12 months.

ARRJF's Price Growth Rating (47) in the null industry is in the same range as PDRX (52). This means that ARRJF’s stock grew similarly to PDRX’s over the last 12 months.

ARRJF's P/E Growth Rating (52) in the null industry is somewhat better than the same rating for PDRX (100). This means that ARRJF’s stock grew somewhat faster than PDRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRJFPDRX
RSI
ODDS (%)
Bearish Trend 2 days ago
29%
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
38%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
52%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
13%
Bullish Trend 2 days ago
32%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
13%
Bullish Trend 2 days ago
29%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
50%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
26%
View a ticker or compare two or three
Interact to see
Advertisement
ARRJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MDIA1.300.03
+2.36%
Mediaco Holding
IFF60.720.42
+0.70%
International Flavors & Fragrances
MRX33.960.21
+0.62%
Marex Group plc
TRON2.17-0.06
-2.69%
Tron Inc
FTEL5.86-0.39
-6.24%
Fitell Corp

ARRJF and

Correlation & Price change

A.I.dvisor tells us that ARRJF and COSM have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARRJF and COSM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRJF
1D Price
Change %
ARRJF100%
N/A
COSM - ARRJF
5%
Poorly correlated
-0.92%
MAHLY - ARRJF
2%
Poorly correlated
N/A
PDRX - ARRJF
0%
Poorly correlated
N/A
AMFPF - ARRJF
0%
Poorly correlated
N/A
MEPDF - ARRJF
0%
Poorly correlated
N/A
More

PDRX and

Correlation & Price change

A.I.dvisor tells us that PDRX and NSVGF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PDRX and NSVGF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDRX
1D Price
Change %
PDRX100%
N/A
NSVGF - PDRX
8%
Poorly correlated
N/A
SHPMY - PDRX
8%
Poorly correlated
N/A
SHPMF - PDRX
1%
Poorly correlated
N/A
ARRJF - PDRX
0%
Poorly correlated
N/A
MEPDF - PDRX
0%
Poorly correlated
N/A
More